When a consultant says you have ulcerative colitis, the sentence is usually incomplete. The clinically meaningful version has a second half: how far does it reach?
That is because ulcerative colitis behaves with unusual predictability about geography. It begins at the rectum, every time, and spreads upwards in one continuous band. There are no gaps. So the only variable is how far up it has gone — and that single measurement does more to shape your treatment than almost anything else.
The four extents
Working outwards from the rectum:
Proctitis
The rectum only — roughly the last 15 centimetres.
This is the commonest picture at diagnosis. Because the inflamed area is small, the systemic consequences are usually modest: blood tests are often entirely normal, weight loss is unusual, and significant anaemia is less common.
But limited is not the same as mild. The rectum is the organ that tells you when and how urgently you need a toilet, and when its lining is ulcerated it does that job badly. Severe urgency, tenesmus — straining with little result — and passing blood and mucus with no stool at all are all typical. Some people with proctitis are even constipated, because the colon above is working normally while the rectum is irritable.
Proctosigmoiditis
Rectum and sigmoid colon — the S-shaped stretch above it.
Symptoms broaden: more cramping, generally low on the left, and more genuine diarrhoea rather than just frequency.
Left-sided or distal colitis
Up to the splenic flexure, the bend where the colon turns across the top of the abdomen under the spleen.
This boundary is more than anatomical trivia. It is roughly as far as a liquid enema will reach, which makes it the dividing line between disease that can be treated topically and disease that needs oral medication.
Extensive colitis and pancolitis
Beyond the splenic flexure, up to and including the whole colon.
With most of the colon inflamed, the systemic picture arrives: anaemia from sustained blood loss, weight loss, fever during flares, and the fatigue that people describe as the worst symptom. Blood tests are much more likely to be abnormal. Flares are more likely to need hospital treatment.
Why the extent decides your treatment
This is the practical payoff, and it is the reason to ask your consultant where your disease stops.
| Extent | Usual first-line route |
|---|---|
| Proctitis | Mesalazine suppository |
| Proctosigmoiditis / left-sided | Mesalazine enema or foam, often with oral mesalazine |
| Extensive / pancolitis | Oral mesalazine, with topical added |
A suppository dissolves in the rectum. An enema travels further, roughly to the splenic flexure. Neither reaches the transverse or right colon, which is why extensive disease needs the drug taken by mouth and delivered through the bloodstream.
The reason this is worth knowing: topical treatment often works better than tablets for disease it can reach, and with less absorbed into the rest of the body. If you have proctitis and have only ever been offered tablets, raising that with your team is reasonable. NICE’s guidance on ulcerative colitis sets out topical aminosalicylates as first line for proctitis and proctosigmoiditis for precisely this reason.
The honest obstacle is that a lot of people quietly do not use suppositories or enemas, because the idea is unappealing and nobody explained the technique. Lying on your left side, after emptying your bowels, before bed, makes an enormous difference to both comfort and retention. It is worth asking an IBD nurse to talk you through it rather than abandoning the most effective treatment for your particular extent.
The lifelong consequence
Extent also sets your bowel cancer surveillance schedule. Risk relates to how much colon has been inflamed and for how long, so:
- Proctitis generally does not require surveillance colonoscopy beyond ordinary population screening.
- Left-sided, extensive and pancolitis enter a surveillance programme, typically starting around ten years after symptoms began, with intervals from one to five years depending on extent, inflammation severity, family history and whether you have primary sclerosing cholangitis.
If you have primary sclerosing cholangitis alongside colitis, surveillance is annual from diagnosis regardless of extent. That is the combination most often missed.
This is a decision made on the basis of your biopsy and colonoscopy report, which is a good reason to know what yours says.
Can it change?
Yes, in both directions.
Roughly a quarter to a third of people diagnosed with proctitis develop more extensive disease over the following decades. Conversely, extent can appear to reduce as inflammation heals. Neither is predictable, though consistent maintenance treatment is associated with a lower chance of progression.
Because of that, a repeat colonoscopy at some stage is normal practice rather than a sign something has gone wrong — the original finding is not assumed to hold for life.
Severity is a separate axis
Worth separating, because the two get conflated. Extent is how much. Severity is how bad right now, graded by the Truelove and Witts criteria:
- Mild — fewer than four stools a day, no systemic upset.
- Moderate — four to six.
- Severe — six or more with blood, plus fever, pulse over 90, anaemia or raised ESR.
You can have severe proctitis and mild pancolitis. The first needs urgent symptom control; the second needs careful long-term management and surveillance. They are different problems and they get different answers.
The two questions to ask
At your next appointment:
- How far does my colitis extend? Proctitis, left-sided, or extensive.
- What surveillance interval does that put me on, and when does it start?
The first tells you whether you are on the right treatment route. The second is a consequence that lasts the rest of your life, and it is routinely never spelled out.
